CLIA

LIAISON® & LIAISON XL® System

LIAISON® QuantiFERON® -TB Gold Plus

Il test DiaSorin LIAISON® QuantiFERON®-TB Gold Plus utilizza la tecnologia di immunodosaggio in chemiluminescenza (CLIA) per la rilevazione dell’interferone-γ (IFN-γ) in campioni di plasma umano prelevati in litio eparina. L’immunodosaggio può identificare le risposte in vitro a un cocktail di antigeni peptidici associati all’infezione da Mycobacterium tuberculosis (M.

Italian

LIAISON® Meridian H. pylori SA

The LIAISON® Meridian H. pylori SA assay is a chemiluminescent immunoassay (CUA) intended for the qualitative determination of Helicobacter pylori (H. pylori) antigen in human stool. The test is an aid in the diagnosis of patients suspected of H. pylori infection and to measure post therapy response from patients who have discontinued therapy for at least 4 weeks.

Undefined

LIAISON® QuantiFERON® Software

LIAISON® QuantiFERON® Software (LQS) is a flexible lab tool that can be installed between LIAISON® XL and LIS to allow you the following features:

 

  • Management of four different workflow scenarios
  • Sample check-in with barcode reader
  • Duplication of individual barcode labels when necessary
  • Schedule retesting of failed samples
  • Repetition of single or multiple patient tubes
  • Automatic interpretation of results
English

LIAISON® QuantiFERON® -TB Gold Plus

The DiaSorinLIAISON® QuantiFERON®-TB Gold assay uses chemiluminescent immunoassay (CLIA) technology for the detection of interferon-γ (IFN-γ) in human lithium heparin plasma specimens. The immunoassay can identify in vitro responses to a peptide antigens cocktail associated with Mycobacterium tuberculosis (M. tuberculosis) infection that stimulates cells in heparinized whole blood collected with the  QuantiFERON® Blood Collection Tubes.

English

LIAISON® XL MUREX Anti-HDV

The LIAISON® XL murex Anti-HDV assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative detection of total antibodies
to hepatitis D virus in human serum and plasma samples. The assay results, in conjunction with other laboratory results and clinical information,
are intended to be used as an aid in the diagnosis of HDV infection and as a screening test for organ and tissue donors.

Undefined

Pages

Subscribe to RSS - CLIA